• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

News

08 January 2015
Selcia scientists have determined the absolute stereochemistry of the structure of teixobactin, a...
03 February 2014
An initiative is under way to develop new drugs for a devastating tropical disease that threatens...

Upcoming Events

3 May 2015 to 7 May 2015
Selcia is attending the SETAC Euorpe 25th Annual Meeting in Barcelona, Spain, on 5-6 May.
11 May 2015 to 13 May 2015
Selcia is attending OBN's Biotrinity biopartnering and investment conference in London.

Selcia Tweets